ClinQueryAgent: A Conversational Agent for Population Health Management

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

Objective: To develop and characterize CLEAR-Med, a dual-agent framework for natural-language analysis of structured clinical data that separates SQL-based invocation from independent validation. Methods: CLEAR-Med uses one agent to translate a question into executable Structured Query Language (SQL), retain the executed query and database result, and produce a draft. Deterministic checks and a separately invoked cross-provider Validation Agent then accept the draft, request one bounded repair, or abstain. We formalized the system as a bounded selective pipeline and evaluated CLEAR-Med's configuration and scalability, and the Invocation Agent's accuracy and consistency on a 25-query development benchmark, using a harmonized 21-site neonatal hypoxic-ischemic encephalopathy table containing 532 de-identified infant records and approximately 1,300 variables. Results: CLEAR-Med completed all six nominal scalability configurations, including 500x1300. Across 25 development-benchmark queries repeated five times, the Invocation Agent answered 83 of 125 responses correctly (66.4%; query-cluster bootstrap 95% CI, 48.0-83.2%), compared with 15 of 125 (12.0%; 95% CI, 3.2-22.4%) for the ungrounded ChatGPT baseline, a paired improvement of 54.4 percentage points (95% CI, 36.8-72.0%). Conclusion: CLEAR-Med provides a general architecture for traceable analysis of structured clinical data: numerical claims remain linked to executed SQL, and unresolved cases can fail closed. The reported experiments characterize CLEAR-Med's configuration and scalability and the Invocation Agent's accuracy, while the formal analysis establishes the encoded-property guarantee of the complete control flow; a prospective full-pipeline evaluation of the validation and abstention stages is the next stage of this work.

Personal health management unfolds over repeated encounters, yet most health AI systems treat each request in isolation. We developed HealthClaw, an open-source agent architecture that updates support as a person's routines, preferences, measurements and risks change. It separates shared safety rules and medical knowledge from private longitudinal memory containing profile facts, reusable procedures and episodic traces. After each episode, induction determines what should update the profile, revise a procedure, remain episodic or be excluded. We evaluated HealthClaw with a synthetic year-long benchmark and nine 200-case biomedical tasks. Across 900 longitudinal support probes, answer accuracy increased from 0.2% with current-query prompting to 45.7% with HealthClaw, while prompt-side context exposure was 71.7% lower than with full-history prompting. In 100 privacy probes, HealthClaw produced higher privacy-aware answer quality and fewer unsafe disclosures than both baselines. Across the biomedical tasks, the mean absolute gain in the task-specific primary metric was 27.0 percentage points, and seven gains remained significant after false-discovery-rate correction. These offline benchmarks support governed, self-evolving memory for longitudinal personal health agents, although clinical effectiveness requires prospective evaluation. HealthClaw is publicly available at https://github.com/HC-Guo/HealthClaw.